Regenerx Biopharmaceuticals Inc (RGRX)
0.0014
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Regenerx Biopharmaceuticals Cash from Operations (TTM): -0.8237M for March 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2023 | -0.8237M |
| December 31, 2022 | -0.9407M |
| September 30, 2022 | -1.045M |
| June 30, 2022 | -1.247M |
| March 31, 2022 | -1.054M |
| December 31, 2021 | -0.9903M |
| September 30, 2021 | -0.907M |
| June 30, 2021 | -0.7152M |
| March 31, 2021 | -0.9822M |
| December 31, 2020 | -1.007M |
| September 30, 2020 | -1.040M |
| June 30, 2020 | -1.090M |
| March 31, 2020 | -1.065M |
| December 31, 2019 | -1.138M |
| September 30, 2019 | -1.055M |
| June 30, 2019 | -1.033M |
| March 31, 2019 | -1.027M |
| December 31, 2018 | -0.8883M |
| September 30, 2018 | -0.799M |
| June 30, 2018 | -0.5842M |
| March 31, 2018 | -0.5793M |
| December 31, 2017 | -0.6631M |
| September 30, 2017 | -0.8854M |
| June 30, 2017 | -1.381M |
| March 31, 2017 | -1.116M |
| Date | Value |
|---|---|
| December 31, 2016 | -1.068M |
| September 30, 2016 | -1.118M |
| June 30, 2016 | -0.474M |
| March 31, 2016 | -0.9816M |
| December 31, 2015 | -0.5253M |
| September 30, 2015 | -0.5784M |
| June 30, 2015 | -1.097M |
| March 31, 2015 | -1.224M |
| December 31, 2014 | -1.704M |
| September 30, 2014 | -1.479M |
| June 30, 2014 | -1.307M |
| March 31, 2014 | -0.911M |
| December 31, 2013 | -0.7816M |
| September 30, 2013 | -0.8014M |
| June 30, 2013 | -0.5489M |
| March 31, 2013 | -0.4256M |
| December 31, 2012 | -0.2742M |
| September 30, 2012 | -0.6632M |
| June 30, 2012 | -2.586M |
| March 31, 2012 | -4.122M |
| December 31, 2011 | -5.42M |
| September 30, 2011 | -5.976M |
| June 30, 2011 | -5.670M |
| March 31, 2011 | -5.127M |
| December 31, 2010 | -4.997M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-1.247M
Minimum
Jun 2022
-0.7152M
Maximum
Jun 2021
-1.008M
Average
-1.036M
Median
Cash from Operations (TTM) Benchmarks
| FluoroPharma Medical Inc | -0.8801M |
| RenovaCare Inc | -4.126M |
| Xeno Transplants Corp | -- |
| Entia Biosciences Inc | -0.7151M |
| OncoVista Innovative Therapies Inc | -0.2644M |